These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27048342)

  • 21. Short-term and long-term effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with renal impairment: a meta-analysis of randomized controlled trials.
    Li R; Wang R; Li H; Sun S; Zou M; Cheng G
    Diabetes Metab Res Rev; 2016 Sep; 32(6):460-9. PubMed ID: 26433213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.
    Li L; Li S; Deng K; Liu J; Vandvik PO; Zhao P; Zhang L; Shen J; Bala MM; Sohani ZN; Wong E; Busse JW; Ebrahim S; Malaga G; Rios LP; Wang Y; Chen Q; Guyatt GH; Sun X
    BMJ; 2016 Feb; 352():i610. PubMed ID: 26888822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of flaxseed supplementation on circulating adiponectin and leptin concentration in adults: A systematic review and meta-analysis of randomized controlled trials.
    Jalili C; Pezeshki M; Askarpour M; Marx W; Hassani B; Hadi A; Ghaedi E
    Phytother Res; 2020 Jul; 34(7):1578-1586. PubMed ID: 32050052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus.
    Kaneko M; Narukawa M
    Diabetes Res Clin Pract; 2016 Jun; 116():171-82. PubMed ID: 27321333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis.
    Min SH; Yoon JH; Hahn S; Cho YM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study.
    Kim YG; Yoon D; Park S; Han SJ; Kim DJ; Lee KW; Park RW; Kim HJ
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28899989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials.
    Chen W; Huang Z; Bi M; Xu X; Zhao N
    Lipids Health Dis; 2017 Mar; 16(1):53. PubMed ID: 28288631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis.
    Gooßen K; Gräber S
    Diabetes Obes Metab; 2012 Dec; 14(12):1061-72. PubMed ID: 22519906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of sitagliptin on markers of beta-cell function: a meta-analysis.
    Riche DM; East HE; Riche KD
    Am J Med Sci; 2009 May; 337(5):321-8. PubMed ID: 19322069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis.
    Guo WQ; Li L; Su Q; Dai WR; Ye ZL
    Value Health; 2017 Dec; 20(10):1427-1430. PubMed ID: 29241903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A; Simental-Mendía LE; Mikhailidis DP; Pirro M; Banach M; Sirtori CR; Ruscica M; Reiner Ž
    J Clin Lipidol; 2018; 12(3):801-809. PubMed ID: 29580713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coffee consumption has no effect on circulating markers of liver function but increases adiponectin concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Linden-Torres E; Zambrano-Galván G; Sahebkar A; Ríos-Mier M; Simental-Mendía LE
    Nutr Res; 2022 Oct; 106():24-34. PubMed ID: 36126527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does statin therapy reduce plasma VEGF levels in humans? A systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A; Ponziani MC; Goitre I; Bo S
    Metabolism; 2015 Nov; 64(11):1466-76. PubMed ID: 26347012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Simental-Mendia LE; Sahebkar A; Rodriguez-Moran M; Zambrano-Galvan G; Guerrero-Romero F
    Curr Pharm Des; 2017; 23(31):4678-4686. PubMed ID: 28545353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do dipeptidyl peptidase IV (DPP-IV) inhibitors cause heart failure?
    Clifton P
    Clin Ther; 2014 Dec; 36(12):2072-2079. PubMed ID: 25453730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sahebkar A; Simental-Mendía LE; Guerrero-Romero F; Golledge J; Watts GF
    Curr Pharm Des; 2016; 22(5):595-608. PubMed ID: 26601964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis.
    Farah D; Leme GM; Eliaschewitz FG; Fonseca MCM
    Diabetes Res Clin Pract; 2019 Mar; 149():47-63. PubMed ID: 30710655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.
    Rehman MB; Tudrej BV; Soustre J; Buisson M; Archambault P; Pouchain D; Vaillant-Roussel H; Gueyffier F; Faillie JL; Perault-Pochat MC; Cornu C; Boussageon R
    Diabetes Metab; 2017 Feb; 43(1):48-58. PubMed ID: 27745828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
    Thornberry NA; Gallwitz B
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):479-86. PubMed ID: 19748065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of dipeptidyl peptidase-4 inhibitors: a review.
    Richard KR; Shelburne JS; Kirk JK
    Clin Ther; 2011 Nov; 33(11):1609-29. PubMed ID: 22071236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.